Cosentyx Sensoready (300 MG) and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Cosentyx Sensoready (300 MG) and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: secukinumab
Brand name: Cosentyx, Cosentyx Sensoready Pen
Synonyms: Secukinumab
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cosentyx Sensoready (300 MG)-Insulin degludec
- Cosentyx Sensoready (300 MG)-Insulin Degludec (U-100) Prefilled Pens
- Cosentyx Sensoready (300 MG)-Insulin Degludec (U-100) Vials
- Cosentyx Sensoready (300 MG)-Insulin Degludec (U-200) Prefilled Pens
- Cosentyx Sensoready (300 MG)-Insulin degludec and liraglutide
- Cosentyx Sensoready (300 MG)-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Cosentyx Sensoready Pen
- Insulin aspart, recombinant Subcutaneous-Cosmegen
- Insulin aspart, recombinant Subcutaneous-Cosopt
- Insulin aspart, recombinant Subcutaneous-Cosopt Ocumeter
- Insulin aspart, recombinant Subcutaneous-Cosopt Ocumeter Plus
- Insulin aspart, recombinant Subcutaneous-Cosopt PF